Clinical Trials Logo

Adrenal Gland Diseases clinical trials

View clinical trials related to Adrenal Gland Diseases.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04948970 Completed - Adrenal Disease Clinical Trials

Steroid Panel for One-step Diagnosis of Adrenal Diseases

Start date: June 21, 2021
Phase:
Study type: Observational

The aim of this study is to develop a one-step diagnostic method for adrenal diseases, Patients with adrenal diseases including non-functioning adrenal adenoma, adrenal Cushing's syndrome, primary aldosteronism, and pheochromocytoma will be recruited. Using mass spectrometry analysis based on a multisteroid panel, serum, urine, saliva, and hair samples of the patients will be analyzed. The diagnostic yield of each and combination of steroids will be evaluated.

NCT ID: NCT04139447 Completed - Adrenal Disease Clinical Trials

DAnalysis of the Distribution of Adrenal Steroids in a Control Population

STEROTEM
Start date: February 2015
Phase:
Study type: Observational

This is a biomedical research study on the determination of adrenal steroids. It has been proposed in recent years as a tool for the diagnostic orientation of an adrenal pathology. The main objective is to analyze the distribution of blood and urinary adrenal steroid values in a population of 60 controls. The secondary objective is to establish reference values for each of these parameters, if their distribution permits, and to study the possible link between the blood pressure level, the orthostatism state, the potassium level and these adrenal steroids.

NCT ID: NCT03718234 Completed - Clinical trials for Congenital Disorders

Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

Start date: January 1, 2019
Phase: Phase 1
Study type: Interventional

This is an open-label, non-randomized crossover design feasibility trial comparing oral hydrocortisone treatment with interval bolus delivery (pulsatile) of subcutaneous hydrocortisone via infusion pump in children with congenital adrenal hyperplasia. Eight children, ages 4-18 yrs, will have 24-hr pharmacokinetic and pharmacodynamic profiles of cortisol, 17-hydroxyprogesterone and androstenedione concentrations while on oral hydrocortisone therapy (admission 1), during an initial trial of the subcutaneous hydrocortisone pump (admission 2), and after 6 weeks of subcutaneous hydrocortisone pump treatment (admission 3). An integrated pharmacokinetic and pharmacodynamic model will be used to determine cortisol, 17-hydroxyprogesterone and androstenedione parameters to compare the duration of time subjects have these concentrations outside acceptable ranges. Funding Source - FDA OOPD

NCT ID: NCT03327142 Completed - Adrenal Tumor Clinical Trials

EUS-guided FNA in the Study of the Adrenal Gland

Start date: December 8, 2015
Phase: N/A
Study type: Observational

To analyze the diagnostic performance, safety, impact on clinical management, predictors of malignancy and cyto-pathological correlation of the EUS-FNA with AG. National multicenter retrospective study. Mailing-SEED partners. Participation: 17 Spanish centers. Inclusion period: April / 2003 to April / 2016 Inclusion criteria: All AG (Left / Right) punctured by EUS. A review of 205 EUS-FNA of AG in 200 patients is included.

NCT ID: NCT02618694 Completed - Pheochromocytoma Clinical Trials

Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study

PostLapAdrnl
Start date: April 2015
Phase: N/A
Study type: Interventional

This randomized comparative study assesses the safety and efficacy of the posterior retroperitoneoscopic adrenalectomy in comparison to the standard, anterior transperitoneal approach and suppose that this new technique is a safe and effective alternative to the standard approach.

NCT ID: NCT01676025 Completed - Adrenal Disease Clinical Trials

Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy

PRA
Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to compare two surgical methods of adrenalectomy. One is called PRA(posterior retroperitoneal adrenalectomy), which is performed through 3 or 4 holes at patient's back. The other is LA(laparoscopic adrenalectomy) which is performed through patient's abdominal cavity after making 3 or 4 holes in the abdomen.

NCT ID: NCT00721929 Completed - Clinical trials for Adrenal Gland Disease

Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

Start date: October 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if certain MRI sequences can accurately diagnose adrenal masses of unknown origin.

NCT ID: NCT00037843 Completed - Clinical trials for Adrenal Gland Neoplasms

Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening

Start date: December 1988
Phase: Phase 3
Study type: Interventional

This is a clinical research study using I-131 Iodocholesterol which is an experimental radioactive chemical that when injected into the vein, is picked up in the adrenal glands and permits visualization with gamma imaging devices. These images are used in diagnosing a variety of adrenal abnormalities.Prior to the injection of I-131 Iodocholesterol, the patient will receive perchlorate capsules to block any uptake of I-131 by the thyroid gland if this is deemed important. The patient will continue to take these capsules throughout the period of imaging, which may last up to 1 week. The injection of I-131 Iodocholesterol will be given into a vein and the patient will return for images on at least 1 and possibly 2 occasions between 3-7 days after injection. If the case requires it, the patient may also be given a steroid in tablet form, dexamethasone, to take orally prior to and after the injection to suppress normal adrenal function so that the abnormal tissues can be more easily detected.